The problem we solve: Other than infection, tissue differentiation is the biggest surgical challenge – where, what and how much to cut. Verbal and visual distractions from 2D monitors lengthen procedures and negatively impact patient outcomes. Current fluorescent guided surgery (FGS) approaches have several major shortcomings: 1) cost; 2) usability; 3) complexity; and 4) low adoption rates. Current FGS solutions are expensive ($1.3M to $2.3M more expensive over 3 years based on 20 surgeries per week and 40 surgical weeks). Current FGS solutions have several usability concerns: black and white, 2D images outside of the surgical field, single focal point, requirement to turn off lights in order to obtain fluorescence, bulky hardy requires extra time (15-30 minutes per procedure) to set up and mechanical arm for camera and light sources are hard to maneuver. The use of external monitors.
About our solution: With AR Imaging, a surgeon puts on AR-enabled glasses (digital loupes) with variable magnification (2x-8x), adjustable color contrasts and voice navigation. Vivid 3D color images of the surgical field and fluorescent imaging significantly improve tissue differentiation and depth perception. Preoperative diagnostic images (e.g. CT, MRI) superimposed on the patient improve situational awareness of the surrounding structures and organs. By revolutionizing clinician visualizations and situational awareness, AR Imaging is focused on eliminating verbal and visual distractions and improving decision making to reduces the time and cost while improving patient outcomes from medical and surgical procedures.Progress to date:
Creator: Michael Riemer
Bio: I am a technology business executive and "accidental" serial entrepreneur who left medical school to start (and exit) my first company. 32 years of B2B enterprise software leadership experience in product management, marketing and business development including 3 exits. Last 10 years leading Industrial IoT and field service applications, platforms and digital ecosystems for connected vehicles and heavy equipment Early executive at Nextel (1993). 7+ years running products (handset, services, data, applications) including creating/launching GTM segment strategy (7 segments, 25M Pops) that delivered $70 ARPU (industry highest), 2.5% churn (industry lowest), 4.5M subscribers (record growth) and 3500% increase in market cap. Unique combination of software, hardware and telecom product management with more than 20 product launches and 5 granted patents Broad industry experience (financial services, heavy equipment, transportation, cybersecurity, telecom, field service). Extensive technology background (IoT, hardware, software, cloud, mobile, voice recognition, AI/ML, Predictive & Prescriptive Analytics) generating >$200M in software contract value.
Title: Chief Executive Officer
Chief Medical Officer, MD, MS BME, FACS, FAAP
Biography: Chairman, Dermatology and Plastic Surgery Institute at the Cleveland Clinic. Performed first near-total face transplant in US and commercialized first neuromodulation implant device.
Title: Chief Medical Officer
Advanced Degree(s): MD, MS BME, FACS, FAAP
CTO, PhD Biomedical Engineering
Biography: Assistant Professor, Biomedical Engineering, University of Akron Expert in medical virtual reality and intraoperative imaging; Principal investigator of multiple research grants from US Air Force, Army, NASA, ODOD, etc; Young Investigator award recipient from International Society of Computer Aided Surgery.
Advanced Degree(s): PhD Biomedical Engineering
CPO, MBA, Finance
Biography: General Manager, Cleveland Clinic – Digital Innovations (AR / VR / AI) Expert in product development for AR / VR / AI. 15+ years in hi-tech focusing on simulation, computer hardware development, software design and business evaluation. Previous employment at Microsoft, Apple, and McKinsey & Co.
Advanced Degree(s): MBA, Finance
AR Imaging uses augmented reality to revolutionize clinical visualizations to enhance tissue differentiation. We do this by providing AR-enabled glasses (digital loupes), that enable the surgeon to view 3D color images of the patient with coregistration of fluorescent contrast agents and pre-operative diagnostic images (e.g. CT, MRI) superimposed on the surgical field.
Fluorescent imaging helps quickly identify tissue perfusion (viability) and helps identify cancerous areas (they light up like a Christmas tree). The superimposed preoperative images provide a highly effective image guided surgery solution that improves decision making and situational awareness.
All targeted procedures have current solutions and related DRGs and ICDs for reimbursements and payments associated with fluorescent and image guided surgery. In addition to providing a major cost savings, these solutions have other shortcomings that impact surgical experiences. This includes:
Specifically, the following value for each user that addresses their respective pain point(s) is listed in the table below:
No updates found .
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.